Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 18Venous Thromboembolism 16Venous Thrombosis 5Pulmonary Embolism 4Treatment of Venous Thromboembolism in Cancer Patients 3Thrombosis 3Multiple Myeloma 3Upper Extremity Deep Vein Thrombosis 2Lung Neoplasms 2Colonic Neoplasms 2Carcinoma, Hepatocellular 2Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urologic Neoplasms 1Urogenital Neoplasms 1Thromboembolism 1Stomach Neoplasms 1Recurrence 1Prostatic Neoplasms 1Prevention of Venous Thromboembolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Myeloproliferative Disorders 1Lymphoma 1Leukemia 1Inflammation 1Immune System Diseases 1Hemorrhage 1Hematologic Neoplasms 1

Interventions

Cyclophosphamide 153Dexamethasone 141Rituximab 85fludarabine 79Lenalidomide 72Cytarabine 70Bortezomib 64fludarabine phosphate 63Gemcitabine 62venetoclax 54Etoposide 53pomalidomide 52pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Rivaroxaban × Clear all
NCT01989845 2017-01-09

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Seoul National University Hospital

Phase 4 Completed
127 enrolled

Hemorrhage, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡